Tuberculosis (TB) remains a significant global health challenge, necessitating improved diagnostic methods for effective control and eradication. This article presents a comprehensive review of the contemporary diagnostic approaches for TB in healthcare settings.
Advancements in molecular biology have led to the development of rapid, sensitive and specific diagnostic tools for TB. Techniques such as Polymerase Chain Reaction (PCR) and Whole Genome Sequencing (WGS) have revolutionized TB diagnostics, facilitating early detection and precise identification of drug-resistant strains.
Imaging techniques like Chest X-rays and Computed Tomography (CT) scans remain integral in TB diagnostics, providing visual evidence of pulmonary abnormalities. However, these techniques are less effective in detecting extrapulmonary TB and in patients co-infected with HIV.
Immunological tests such as the Tuberculin Skin Test (TST) and the Interferon Gamma Release Assays (IGRAs) are widely used for TB diagnosis. While TST is simple and inexpensive, it has limitations in specificity and sensitivity. IGRAs, on the other hand, offer better specificity but are more expensive and require sophisticated laboratory infrastructure.
Microbiological techniques like sputum smear microscopy and culture remain the gold standard for TB diagnosis. However, these methods are time-consuming and have reduced sensitivity in patients with paucibacillary disease or children.
While significant advancements have been made in TB diagnostics, no single technique is universally applicable due to variations in sensitivity, specificity, cost, and infrastructural requirements. An effective diagnostic approach should, therefore, incorporate a combination of these techniques tailored to the specific needs of the patient population and healthcare setting. Continued research and innovation are imperative to unmask TB and curb its global impact.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation